Shockwave Medical Announces Global Launch of New Peripheral Intravascular Lithotripsy Catheter
Shockwave M5+ IVL Catheter Broadens Options for Treatment of Peripheral ArteriesSANTA CLARA, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Shockwave...
News
Celsion Corporation Reports 2021 Financial Results and Provides Business Update
Focus on Cancer Immunotherapy and Next-Generation Vaccines and a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. Eastern...
Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors
NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the...
Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call
Call Scheduled for Today, Thursday, March 31, 2022 at 5:00 pm ETHIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE NEWSWIRE) --...
Outlook Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for ONS-5010 as a Treatment for Wet AMD
ONS-5010 / LYTENAVA™ (bevacizumab-vikg), if approved, expected to receive 12 years of marketing exclusivityISELIN, N.J., March 31, 2022 (GLOBE NEWSWIRE)...
Philips enables seamless echocardiography workflows with the launch of Ultrasound Workspace at ACC 2022
Clinicians reviewing ultrasound scan March 31, 2022 Industry leading vendor-neutral solution for automated 2D and 3D quantification for browser-accessible echocardiography...
Ring Therapeutics Announces Publication Highlighting the Immune Favorability of Commensal Anelloviruses
– First description of new, comprehensive anellovirus antibody analysis tool, AnelloScan – – Cross-sectional study supports that anelloviruses are associated with...
Daré Bioscience Reports Full-Year 2021 Financial Results and Provides a Company Update
Entered into an exclusive global license agreement with Organon to commercialize XACIATO™ (clindamycin phosphate vaginal gel, 2%) that includes a $10...
Cidara Therapeutics Announces the Completion of Dosing the First Cohort of Healthy Volunteers in the Phase 1 Trial of CD388 in Development for Universal Prevention and Treatment of Seasonal and Pandemic Influenza
CD388 is a drug-Fc conjugate (DFC) from Cidara’s Cloudbreak® platform and is designed to transform the standard of care for...
Galectin Therapeutics Reports 2021 Financial Results and Provides Business Update
NORCROSS, Ga., March 31, 2022 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target...
Jasper Therapeutics to Present Updated Data on JSP191 Conditioning in SCID Patients at the 2022 Clinical Immunology Society Annual Meeting
REDWOOD CITY, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic...
VBL Therapeutics to Host In-Person Key Opinion Leader Seminar on Ovarian Cancer
Three leading experts in gynecological oncology will discuss treatment landscape and unmet needs in ovarian cancer Event on Monday, April...
Catalyst Biosciences Reports Fourth Quarter and Year-end 2021 Operating & Financial Results and Provides a Corporate Update
SOUTH SAN FRANCISCO, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and...
Konica Minolta Healthcare Appoints New President and CEO
Fumi Hayashida, KMHA Fumi Hayashida, President and CEO, Konica Minolta Healthcare Americas, Inc.WAYNE, N.J., March 31, 2022 (GLOBE NEWSWIRE) --...
Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia®: The Journal of the Alzheimer’s Association
Results Support Further Exploration of Therapeutic Potential of Lomecel-B to Slow Cognitive Decline, Improve Quality of Life for Alzheimer’s Patients...
Portage Biotech Provides Update on Clinical-Stage and Development Programs
Preliminary safety data suggests lead iNKT agonists, PORT-2 and PORT-3, are well tolerated supporting continued development Company continues to work...
OrthoPediatrics to Participate in the 21st Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 31, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on...
Rapid Therapeutic Science Laboratories Announces 1-for-25 Reverse Stock Split
DALLAS, Texas, March 31, 2022 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) ("Rapid Therapeutic" or the "Company"),...
Science 37® Adds Acclaimed Researcher and Oncologist, Dr. Shaalan Beg to Bolster Therapeutic Depth
Addition of Dr. Beg provides Science 37 with expertise to apply more decentralized clinical trial methodologies to the industry’s largest...
Incyclix Bio Announces $30 Million Series B Financing Led by Boxer Capital
Funds to support clinical development of INX-315, the company’s lead Cyclin-Dependent Kinase 2 inhibitor Sid Subramony, Ph.D., of Boxer Capital...
